Rituximab and Wegener's granulomatosis: Are B cells a target in vasculitis treatment?

Authors

  • Michael C. Sneller

    Corresponding author
    1. National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland
    • National Institute of Allergy and Infectious Diseases, NIH, Building 10, Room 11b-13, Bethesda, MD 20892-1876
    Search for more papers by this author

Ancillary